INTEVAC INC (IVAC)

US4611481080 - Common Stock

4.39  +0.3 (+7.33%)

After market: 4.39 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to IVAC. IVAC was compared to 32 industry peers in the Technology Hardware, Storage & Peripherals industry. While IVAC has a great health rating, there are worries on its profitability. IVAC is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

IVAC had negative earnings in the past year.
In the past year IVAC has reported a negative cash flow from operations.
In multiple years IVAC reported negative net income over the last 5 years.
In multiple years IVAC reported negative operating cash flow during the last 5 years.

1.2 Ratios

IVAC's Return On Assets of -7.79% is in line compared to the rest of the industry. IVAC outperforms 40.63% of its industry peers.
The Return On Equity of IVAC (-10.56%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -7.79%
ROE -10.56%
ROIC N/A
ROA(3y)-0.27%
ROA(5y)0.18%
ROE(3y)-1.52%
ROE(5y)-0.46%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

IVAC's Gross Margin of 38.41% is fine compared to the rest of the industry. IVAC outperforms 71.88% of its industry peers.
In the last couple of years the Gross Margin of IVAC has grown nicely.
IVAC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5Y2.24%

7

2. Health

2.1 Basic Checks

IVAC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IVAC has more shares outstanding
IVAC has more shares outstanding than it did 5 years ago.
IVAC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 1.84 indicates that IVAC is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.84, IVAC is in line with its industry, outperforming 53.13% of the companies in the same industry.
IVAC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.84
ROIC/WACCN/A
WACC9.8%

2.3 Liquidity

A Current Ratio of 4.10 indicates that IVAC has no problem at all paying its short term obligations.
IVAC's Current ratio of 4.10 is amongst the best of the industry. IVAC outperforms 81.25% of its industry peers.
IVAC has a Quick Ratio of 2.76. This indicates that IVAC is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.76, IVAC belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.1
Quick Ratio 2.76

1

3. Growth

3.1 Past

IVAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.88%, which is quite impressive.
IVAC shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.24%.
Measured over the past years, IVAC shows a very negative growth in Revenue. The Revenue has been decreasing by -11.15% on average per year.
EPS 1Y (TTM)30.88%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q41.67%
Revenue 1Y (TTM)47.24%
Revenue growth 3Y0.36%
Revenue growth 5Y-11.15%
Revenue growth Q2Q14.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y28.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.11%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IVAC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IVAC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

IVAC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTEVAC INC

NASDAQ:IVAC (4/26/2024, 7:00:02 PM)

After market: 4.39 0 (0%)

4.39

+0.3 (+7.33%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap116.69M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.79%
ROE -10.56%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 38.41%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.1
Quick Ratio 2.76
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)30.88%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y28.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)47.24%
Revenue growth 3Y0.36%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y